Aldosterone, mineralocorticoid receptors and vascular inflammation

Molecular and Cellular Endocrinology

Volumn 217, Issue 1-2, 2004, Pages 263-269

  Funder, John W ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Glucocorticoids; Metabolic stress; NADH; Reactive oxygen species; Redox state

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR;

CARDIOVASCULAR INFLAMMATION; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HORMONAL REGULATION; HORMONE METABOLISM; MOLECULAR DYNAMICS; NONHUMAN; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RECEPTOR BLOCKING; TISSUE INJURY;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; GLUCOCORTICOIDS; HUMANS; MINERALOCORTICOIDS; RECEPTORS, MINERALOCORTICOID; VASCULITIS;

EID: 2342454479     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.10.054     Document Type: Conference Paper

References (41)

1. Agarwal A.K., Mune T., Monder C., White P.C. NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterisation of cDNA from sheep kidney. J. Biol. Chem. 269:1994;25959-25962
2. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105:1994;R11-R17
3. Alzamora R., Michea L., Marusic E.T. Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension. 35:2000;1044-1099
4. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 237:1987;268-275
5. Coghlan, J.P., Blair-West, J.R., 1967. Aldosterone. In: Gray, C.H., Bacharach, A.I. (eds.), Hormones in Blood. Academic Press, London and New York, pp. 391-488.
6. Edwards C.R., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.A., de Kloet E.R., Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet. 29:1988;986-989
7. Fimognari G.M., Fanestil D.D., Edelman I.S. Induction of RNA and protein synthesis in the action of aldosterone in the rat. Am. J. Physiol. 213(4):1967;954-962
8. Funder J.W. Enzymes and receptors: challenges and future directions. Steroids. 59:1994;164-169
9. Funder J.W., Feldman D., Edelman I.S. The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone. Endocrinology. 92:1973;994-1004
10. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated. Science. 242:1988;583-585
11. Funder J.W., Pearce P.T., Smith R., Campbell J. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology. 125:1989;2224-2226
12. Funder J.W., Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology. 137:1996;5264-5268
13. Gomez-Sanchez E.P., Venkataraman M.T., Thwaites D., Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol. 258:1990;E649-E653
14. Haseroth K., Gerdes D., Berger S., Feuring M., Gunther A., Herbst C., Christ M., Wehling M. Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem. Biophys. Res. Comm. 226:1999;257-261
15. Kitagawa H., Yanagisawa J., Fuse H., Ogawa S., Yogiashi Y., Okuno A., Nagasawa H., Nakajima T., Matsumoto T., Kato S. Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Mol. Cell. Biol. 22:2002;3698-3706
16. + channels. Steroids. 60:1995;114-119
17. Krozowski Z.S., Funder J.W. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc. Natl. Acad. Sci. USA. 80:1983;6056-6060
18. Makino Y., Okamoto K., Yoshikawa N., Aoshima M., Hirota K., Yodoi J., Umesono K., Makino I., Tanaka H. Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. J. Clin. Invest. 98:1996;2469-2477
19. Mihailidou, A.S., Mardini, M., Funder, J.W., Rapid, non-genomic effects of aldosterone in the heart mediated by εPKC. Endocrinology (in press).
20. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5:1984;25-44
21. Myles K., Funder J.W. Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Am. J. Physiol. 270:1996;E601-E607
22. New M.I., Levine L.S., Biglieri E.G., Pareira J., Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J. Clin. Endocrinol. Metab. 44:1977;924-933
23. New M.I., Wilson R.C. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc. Natl. Acad. Sci. USA. 96:1999;12790-12797
24. Odermatt A., Arnold P., Frey F.J. The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. J. Biol. Chem. 276:2001;28484-28492
25. Pearce P., Funder J.W. High affinity aldosterone binding sites (Type I receptors) in rat heart. Clin. Exp. Pharmacol. Physiol. 14:1987;859-866
26. Piwien-Pilipuk G., Ayala A., Machado A., Galigniana M.D. Impairment of mineralocorticoid receptor (MR)-dependent biological response by oxidative stress and aging. J. Biol. Chem. 277:2002;11896-11903
27. Qin W., Rudolph A.E., Bond B.R., Rocha R., Blomme E.A.G., Goellner J.J., Funder J.W., McMahon E.G. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ. Res. 93:2003;69-76
28. Rocha R., Chander P.N., Zuckerman A., Stier C.T. Jr. Role of aldosterone in renal vascular injury in stroke prone hypertensive rats. Hypertension. 33:1999;232-237
29. Rocha R., Rudolph A.E., Frierdich G.E., Nachowiak D.A., Kekec B.K., Blomme E.A., McMahon E.G., Delyani J. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am. J. Physiol. 283:2002a;H1802-H1810
30. Rocha R., Martin-Berger C.L., Yang P., Scherrar R., Delyani J., McMahon E. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology. 143:2002b;4828-4836
31. Rousseau G., Baxter J.D., Funder J.W., Edelman I.S., Tomkins G.M. Glucocorticoid and mineralocorticoid receptors for aldosterone. J. Steroid Biochem. 3:1972;219-227
32. Rudolph, A., et al., 2003. Mol. Cell. Endocrinol., in press.
33. Rutter J., Reick M., Wu L.C., McKnight S.L. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science. 293:2001;510-514
34. Sato A., Funder J.W. High glucose stimulates aldosterone-induced hypertrophy via Type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology. 137:1996;4145-4153
35. Stewart P.M., Corrie J.E.T., Shackleton C.H.L., Edwards C.R.W. The syndrome of 'apparent mineralocorticoid excess'; a defect in the cortisol-cortisone shuttle. J. Clin. Invest. 82:1988;340-349
36. Stewart, P., 2003. Mol. Cell. Endocrinol., in press.
37. Ward M.R., Kanellakis P., Ramsey D., Funder J.W., Bobik A. Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries. Circulation. 104:2001;467-472
38. Wehling M., Neylon C.B., Fullerton M., Bobik A., Funder J.W. Nongenomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ. Res. 76:1995;973-979
39. Young M.J., Funder J.W. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt induced cardiac fibrosis. Am. J. Physiol. 271:1996;E883-E888
40. Young M.J., Moussa L., Dilley R., Funder J.W. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11βhydroxysteroid dehydrogenase inactivation. Endocrinology. 144:2003;1121-1125
41. Zhang Q., Piston D.W., Goodman R.H. Regulation of corepressor function by nuclear NADH. Science. 295:2002;1895-1897